Join us for our popular annual afterwork networking event in Suisse Romande, hosted in collaboration with Debiopharm, at their headquarters in Lausanne on Thursday, September 25th, start at 5.00 pm.
This year’s event will spotlight Antibody Drug Conjugates (ADCs), the role they play in reshaping anticancer treatments and how strategic partnerships and business development can unlock value for cancer patients.
We’re thrilled to welcome speakers:
- Björn Hock, Chief Development Officer at Tubulis
- Sophie Brachet, Head of Early Commercial and Access at Debiopharm
- Ilona Kotala, Business Development of Technologies Manager at Debiopharm.
- Filippo Mulinacci, Chief Business Officer at Araris
- Solange Peters, Full Professor, Chair of Medical Oncology at Lausanne University Hospital
Following the talks, enjoy a relaxed networking apéro with fellow professionals.
Agenda:
🕔 17:00 – Doors open
🕡 17:30 – Program begins
🥂 19:30 – Networking apéro
